QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

Author's Avatar
Apr 14, 2023

Launch of cell-free DNA (cfDNA) next-generation sequencing kits to test liquid biopsies // Study to demonstrate QIAGEN’s expertise in detecting disease-relevant cfDNA mutations // New pan-cancer panels for digital PCR platform QIAcuity to be launched in fall 2023